The gut microbiome and microbial translocation in multiple sclerosis

被引：47
|
作者：
Mirza, Ali [1 ,2 ]
Mao-Draayer, Yang [3 ]
机构：
[1] Univ Michigan, Sch Med, Dept Microbiol & Immunol, 4258 Alfred Taubman Biomed Sci Res Bldg, Ann Arbor, MI 48109 USA
[2] Univ Michigan, Sch Med, Dept Neurol, 4258 Alfred Taubman Biomed Sci Res Bldg, Ann Arbor, MI 48109 USA
[3] Univ Michigan, Sch Med, Dept Neurol, 4015 Alfred Taubman Biomed Sci Res Bldg, Ann Arbor, MI 48109 USA
来源：
CLINICAL IMMUNOLOGY | 2017年 / 183卷
关键词：
Multiple sclerosis; Microbiome; CNS; Gut-brain axis; Microbial translocation; Intestinal permeability; CHAIN FATTY-ACIDS; BUTYRATE-PRODUCING BACTERIA; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; PATTERN-RECOGNITION RECEPTORS; INTESTINAL BARRIER FUNCTION; INFLAMMATORY-BOWEL-DISEASE; TOLL-LIKE RECEPTORS; REGULATORY T-CELLS; FAECALIBACTERIUM-PRAUSNITZII; FECAL MICROBIOTA;
D O I：
10.1016/j.clim.2017.03.001
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
Individuals with multiple sclerosis (MS) have a distinct intestinal microbial community (microbiota) and increased low-grade translocation of bacteria from the intestines into the circulation. The observed change of intestinal bacteria in MS patients regulate immune functions involved in MS pathogenesis. These functions include: systemic and central nervous system (CNS) immunity (including peripheral regulatory T cell function), the blood-brain barrier (BBB) permeability and CNS-resident cell activity. This review discusses the MS intestinal microbiota implication on MS systemic- and CNS-immunopathology. We introduce the possible contributions of MS low-grade microbial translocation (LG-MT) to the development of MS, and end on a discussion on microbiota therapies for MS patients. (C) 2017 Elsevier Inc. All rights reserved.
引用
收藏
页码：213 / 224
页数：12
相关论文
共 50 条
  • [41] Exploring the gut microbiome in multiple sclerosis via the international ms microbiome study (IMSMS)
    Zhou, X.
    Singh, S.
    Mendoza, M.
    Baumann, R.
    Landefeld, J.
    Casaccia, P.
    Sand, I. Katz
    Xia, Z.
    Weiner, H.
    Chitnis, T.
    Chandran, S.
    Connick, P.
    Oteagui, D.
    Castillo-Trivino, T.
    Caillier, S.
    Santaniello, A.
    Ackermann, G.
    Humphrey, G.
    Negrotto, L.
    Farez, M.
    Hohlfeld, R.
    Probstel, A. -K.
    Jia, X.
    Graves, J.
    Baror, A.
    Wekerle, H.
    Oksenberg, J.
    West, T.
    Correale, J.
    Cree, B.
    Hauser, S.
    Knight, R.
    Baranzini, S.
    MULTIPLE SCLEROSIS JOURNAL, 2020, 26 (3_SUPPL) : 437 - 437
  • [42] The Role of the Gut Microbiome in Multiple Sclerosis Risk and Progression: Towards Characterization of the "MS Microbiome"
    Probstel, Anne-Katrin .
    Baranzini, Sergio E.
    NEUROTHERAPEUTICS, 2018, 15 (01) : 126 - 134
  • [43] THE STUNTING SYNDROME DEVELOPS IN CHILDREN WITH INCREASED MICROBIAL TRANSLOCATION AND ATTENUATED EVOLUTION OF THE GUT MICROBIOME
    Zambruni, Mara
    Vigo, Natalia I.
    Acosta, Gonzalo J.
    Riveros, Maribel
    Nigalye, Maitreyee
    Somasunderam, Anoma
    Ajami, Nadim J.
    Cabada, Miguel M.
    Ochoa, Theresa J.
    Utay, Netanya S.
    AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2017, 95 (05): : 525 - 525
  • [44] Genetic risk score in multiple sclerosis is associated with unique gut microbiome
    Noha S. Elsayed
    Robert K. Valenzuela
    Terrie Kitchner
    Thao Le
    John Mayer
    Zheng-Zheng Tang
    Vishnu R. Bayanagari
    Qiongshi Lu
    Paula Aston
    Karthik Anantharaman
    Sanjay K. Shukla
    Scientific Reports, 13
  • [45] Genetic risk score in multiple sclerosis is associated with unique gut microbiome
    Elsayed, Noha S.
    Valenzuela, Robert K.
    Kitchner, Terrie
    Le, Thao
    Mayer, John
    Tang, Zheng-Zheng
    Bayanagari, Vishnu R.
    Lu, Qiongshi
    Aston, Paula
    Anantharaman, Karthik
    Shukla, Sanjay K.
    SCIENTIFIC REPORTS, 2023, 13 (01)
  • [46] Multiple sclerosis and the microbiota Progress in understanding the contribution of the gut microbiome to disease
    Engelenburg, Hendrik J.
    Lucassen, Paul J.
    Sarafian, Joshua T.
    Parker, William
    Laman, Jon D.
    EVOLUTION MEDICINE AND PUBLIC HEALTH, 2022, 10 (01) : 277 - 294
  • [47] Mapping the Baseline Gut Microbiome Landscape in People at Risk for Multiple Sclerosis
    Xia, Zongqi
    White, Charles
    Zong, Wei
    Gaiteri, Chris
    Jia, Wei
    Gu, Yian
    Kostic, Aleksandar
    Tseng, George
    De Jager, Philip
    NEUROLOGY, 2020, 94 (15)
  • [48] Ecological and functional alterations of the gut microbiome in different stages of multiple sclerosis
    Takewaki, D.
    Suda, W.
    Sato, W.
    Takayasu, L.
    Miyake, S.
    Hattori, M.
    Yamamura, T.
    MULTIPLE SCLEROSIS JOURNAL, 2020, 26 (3_SUPPL) : 437 - 437
  • [49] The Gut Microbiome in Relapsing Multiple Sclerosis Patients Compared to Controls.
    Umeton, Raffaella
    Eleftheriou, Evdokia
    Nedelcu, Simona
    Hall, Lauren
    Contreras, Ana Luisa Maldonado
    Ward, Doyle
    McCormick, Beth
    Ionete, Carolina
    NEUROLOGY, 2018, 90
  • [50] The metabolic potential of the paediatric-onset multiple sclerosis gut microbiome
    Mirza, Ali, I
    Zhu, Feng
    Knox, Natalie
    Forbes, Jessica D.
    Bonner, Christine
    Van Domselaar, Gary
    Bernstein, Charles N.
    Graham, Morag
    Marrie, Ruth Ann
    Hart, Janace
    Yeh, E. Ann
    Arnold, Douglas L.
    Bar-Or, Amit
    O'Mahony, Julia
    Zhao, Yinshan
    Hsiao, William
    Banwell, Brenda
    Waubant, Emmanuelle
    Tremlett, Helen
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2022, 63
12345